Humana Inc. (HUM) dropped by -0.01 or -0.02 points during the last session to $198.48 per share. One of the highlights of the day was the net money flow figure, which stood at $11.16 million even as the stock accepted $55.63 million in upticks but rejected $44.47 million in downticks. The up/down ratio for the last observation was a 1.25. The 1-week percentage change for the stock price is registered at -1.58%.A block transaction occurred with $10.84 million in upticks and $0 million in downticks while the up/down ratio was calculated to be 0. The stock witnessed a net inflow of $10.84 million at the end of the block trade.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Humana Inc. has lost 1.62% in the last five trading days and dropped 2.58% in the last 4 weeks. Humana Inc. is up 15.88% in the last 3-month period. Year-to-Date the stock performance stands at -2.58%. Humana Inc. (NYSE:HUM) witnessed a decline in the market cap on Wednesday as its shares dropped 0.01% or 0.02 points. After the session commenced at $198.58, the stock reached the higher end at $199.83 while it hit a low of $197.735. With the volume soaring to 971,754 shares, the last trade was called at $198.48. The company has a 52-week high of $217.8. The company has a market cap of $29,594 million and there are 149,101,180 shares in outstanding. The 52-week low of the share price is $150.
Company has reported several Insider transactions to the SEC, on Feb 29, 2016, Brian P. Leclaire (SVP & Chief Information Off.) sold 183 shares at 176.11 per share price.On Mar 12, 2015, James E Murray (EVP & COO) sold 35,220 shares at 160.93 per share price.On Feb 27, 2015, David A Jr/ky Jones (director) sold 6,100 shares at 165.39 per share price.
Humana Inc Last issued its quarterly earnings results on Nov 4, 2016. The company reported $3.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.03. Analyst had a consensus of $3.15. The company had revenue of $13690.00 million for the quarter, compared to analysts expectations of $13412.76 million. The companys revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.16 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Humana Inc was Resumed by BofA/Merrill to Buy on Jan 27, 2017. Humana Inc was Downgraded by Stifel on Jan 24, 2017 to Hold, Lowers Price Target to $ 210 from a previous price target of $214 .Humana Inc was Initiated by Piper Jaffray to Overweight on Jan 4, 2017. Humana Inc was Downgraded by Cantor Fitzgerald to Hold on Dec 7, 2016. Humana Inc was Upgraded by Credit Suisse to Outperform on Nov 11, 2016.
Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The companys products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers compensation, and administrative services to those who self-insure their employee health plans.